by Ksil20@Nw-wsite | May 4, 2021
Therapeutic area: CNS, Psychiatric Disorders Disease: Schizophrenia Monogenic inroad: DISC1 Cellular Model: Patient derived glutamatergic neurons Project Origin: ZI Mannheim, Prof. Andreas Meyer-Lindenberg Medical need:Â Schizophrenia is a chronic and severe mental...
by Ksil20@Nw-wsite | Apr 16, 2021
Therapeutic area: CNS, neurodegenerative disorders Disease: Parkinson’s Disease Monogenic inroad: Alpha Synuclein (SNCA) and LRRK2 (G2019S) Cellular Model: Patient-derived cell lines Project Origin: University of Luxembourg, Prof. Rejko Krüger Medical...
by Ksil20@Nw-wsite | Apr 9, 2021
Therapeutic area: CNS, Psychiatric Disorders Disease: Autism Spectrum Disorders Monogenic inroad: SHANK 3 Cellular Model: Patient-derived cortical (glutamatergic) neurons Project Origin: I-Stem, Dr. Alexandra Benchoua & Prof. Marc Peschanski Medical need:...
